Dorothy Gotlib1, Jolene R Bostwick1, Seema Calip1, Elizabeth Perelstein1, Jacob E Kurlander1, Thomas Fluent1. 1. Drs. Gotlib, MD, Calip, MD, and Fluent, MD, Michigan Medicine, Department of Psychiatry, Ann Arbor, MI. Dr. Bostwick, PharmD, BCPS, BCPP, University of Michigan College of Pharmacy, Ann Arbor, MI. Dr. Perelstein, BS, Washington St. Louis School of Medicine, Department of Neurology, St. Louis, Missouri. Dr. Kurlander, MD, MS, Michigan Medicine, Division of Gastroenterology, Ann Arbor, MI.
Abstract
OBJECTIVES: To determine the volume and nature (or topic) of consultations submitted to a psychiatric pharmacist embedded in an ambulatory psychiatry clinic, within a tertiary care academic medical center and to increase our understanding about the ways in which providers consult with an available psychiatric pharmacist. EXPERIMENTAL DESIGN: Authors analyze and describe the ambulatory psychiatric pharmacist consultation log at an academic ambulatory clinic. All consultation questions were submitted between July 2012 and October 2014. PRINCIPAL OBSERVATIONS: Psychiatry residents, attending physicians, and advanced practice nurse practitioners submitted 280 primary questions. The most common consultation questions from providers consulted were related to drug-drug interactions (n =70), drug formulations/dosing (n =48), adverse effects (n =43), and pharmacokinetics/lab monitoring/cross-tapering (n =36). CONCLUSIONS: This is a preliminary analysis that provides information about how psychiatry residents, attending physicians, and advanced practice nurse practitioners at our health system utilize a psychiatric pharmacist. This collaborative relationship may have implications for the future of psychiatric care delivery.
OBJECTIVES: To determine the volume and nature (or topic) of consultations submitted to a psychiatric pharmacist embedded in an ambulatory psychiatry clinic, within a tertiary care academic medical center and to increase our understanding about the ways in which providers consult with an available psychiatric pharmacist. EXPERIMENTAL DESIGN: Authors analyze and describe the ambulatory psychiatric pharmacist consultation log at an academic ambulatory clinic. All consultation questions were submitted between July 2012 and October 2014. PRINCIPAL OBSERVATIONS: Psychiatry residents, attending physicians, and advanced practice nurse practitioners submitted 280 primary questions. The most common consultation questions from providers consulted were related to drug-drug interactions (n =70), drug formulations/dosing (n =48), adverse effects (n =43), and pharmacokinetics/lab monitoring/cross-tapering (n =36). CONCLUSIONS: This is a preliminary analysis that provides information about how psychiatry residents, attending physicians, and advanced practice nurse practitioners at our health system utilize a psychiatric pharmacist. This collaborative relationship may have implications for the future of psychiatric care delivery.
Entities:
Keywords:
adverse effects; drug information; drug interactions; psychopharmacology; quality of health care; referral and consultation
Authors: Kathleen C Thomas; Alan R Ellis; Thomas R Konrad; Charles E Holzer; Joseph P Morrissey Journal: Psychiatr Serv Date: 2009-10 Impact factor: 3.084
Authors: Shannon M L Furbish; Miranda E Kroehl; Danielle F Loeb; Huong Mindy Lam; Carmen L Lewis; Jennifer Nelson; Zeta Chow; Katy E Trinkley Journal: J Pharm Pract Date: 2016-08-01
Authors: Kimberly B Tallian; Jan D Hirsch; Grace M Kuo; Cathy A Chang; Todd Gilmer; Mindl Messinger; Pauline Chan; Charles E Daniels; Kelly C Lee Journal: J Am Pharm Assoc (2003) Date: 2012
Authors: Richard J Silvia; Kelly C Lee; Jolene R Bostwick; Carla D Cobb; Lisa W Goldstone; Tera D Moore; Gregory H Payne; Jessica L Ho Journal: Ment Health Clin Date: 2020-11-05